INS and metabolic syndrome: The diagnosis is based on evidence of hepatic steatosis, confirmed via imaging or histology, along with at least one of the following: overweight or obesity, type 2 diabetes mellitus, or metabolic dysfunction—such as dyslipidemia, elevated blood pressure, or insulin resistance [3].